EUVIMEDEUVIMED entdecken
Crossref

Balancing Release and Permeation Rates in Cyclosporine Amorphous Solid Dispersions

Dishan D Shah iD, Zhuangyan Xu, Gregory T Knipp iD, Wenzhan Yang, Stacey Marden, Dedong Wu, Liping Zhou iD, Lynne S Taylor iD

Molecular Pharmaceutics · 2026

DOI: 10.1021/acs.molpharmaceut.6c00612 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Dishan D Shah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, Indiana47907, United States. Hauptthemen laut MEDLINE: Cyclosporine. Die Arbeit nennt 61 Literaturangaben. Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The solubility advantage of an amorphous drug can be realized only when it releases at a sufficiently rapid rate from its amorphous solid dispersion (ASD). Herein, we evaluated the impact of a plasticizer, glyceryl tributyrate (GTB), on the release of a poorly soluble drug with a high glass transition temperature (Tg). Cyclosporine has a Tg of 124 °C and was formulated as an ASD with hydroxypropyl methylcellulose acetate succinate (HPMCAS). Binary and ternary ASDs were prepared using solvent evaporation, their Tgs were measured using differential scanning calorimetry, and surface area normalized release rates were determined. The drug-rich phase formed above the amorphous solubility was characterized for composition and size. Drug flux following release from the ASD was measured across Caco-2 cell monolayers. Cyclosporine released at a substantially faster rate from ternary ASDs containing GTB as compared to the corresponding binary ASD. This improvement was attributed to a decrease in Tg upon plasticization due to GTB increasing molecular mobility. Addition of GTB, however, reduced the amorphous solubility of cyclosporine resulting in a decrease in the transport rate across the Caco-2 cell monolayer. These observations may have implications for drug absorption. Ultimately, it is expected that the in vivo performance of these ternary ASDs would be determined by the interplay between the enhanced release rate and the decreased permeation rate of the drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclosporineHumansCaco-2 CellsSolubilityCalorimetry, Differential ScanningPermeabilityPlasticizersDrug LiberationBulk DrugsMethylcelluloseTransition TemperatureChemistry, Pharmaceutical

Stichwörter der Autor:innen

amorphouspermeationplasticizerreleasesolubility

Substanzen

Cyclosporinehydroxypropylmethylcellulose acetate succinatePlasticizersBulk DrugsMethylcellulose

Autor:innen und Institutionen

  • Department of Industrial and Molecular Pharmaceutics, College of Pharmacy, Purdue University, West Lafayette, Indiana47907, United States.
  • Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Boston, Massachusetts02451, United States.

ORCID-Profile: Dishan D Shah, Gregory T Knipp, Liping Zhou, Lynne S Taylor

Förderung

  • AstraZeneca

Zitieren

APA

Shah, D. D., Xu, Z., Knipp, G. T., Yang, W., Marden, S., Wu, D., Zhou, L., & Taylor, L. S. (2026). Balancing Release and Permeation Rates in Cyclosporine Amorphous Solid Dispersions. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00612

Vancouver

Shah DD, Xu Z, Knipp GT, Yang W, Marden S, Wu D, et al. Balancing Release and Permeation Rates in Cyclosporine Amorphous Solid Dispersions. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.6c00612

BibTeX
@article{Shah2026,
  author = {Shah, Dishan D and Xu, Zhuangyan and Knipp, Gregory T and Yang, Wenzhan and Marden, Stacey and Wu, Dedong and Zhou, Liping and Taylor, Lynne S},
  title = {Balancing Release and Permeation Rates in Cyclosporine Amorphous Solid Dispersions},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  doi = {10.1021/acs.molpharmaceut.6c00612}
}
Kostenlos starten →